Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Sep 15, 2022; 14(9): 1758-1770
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1758
Figure 3
Figure 3 The overall survival and progression-free survival of two groups. A: The cumulative overall survival of the endoscopic debulking resection (EdR) + chemoradiotherapy (CRT) and EdR groups; B: The cumulative progression-free survival of the EdR + CRT and EdR groups. CRT: Chemoradiotherapy; EdR: Endoscopic debulking resection; OS: Overall survival.